"Gerald Pierone Jr., M.D. - Has performed over 20,000 procedures with dermal fillers that include Bellafill® (Artefill®), Sculptra®, Radiesse®, Restlyane®, Belotero®, Voluma® and Juvederm®. Dr. Pierone is the leading injector of Bellafill® in the United States and is a nationally recognized trainer and researcher."

During the past decade, Dr Gerald Pierone Jr conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Dr Gerald Pierone Jr" are "HIV Infections" (2 trials). Many other conditions were trialed in "Dr Gerald Pierone Jr" in a lesser frequency.

Most popular intervention types in "Dr Gerald Pierone Jr" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Didanosine" (1 trials), "Lamivudine/Zidovudine" (1 trials), "Nelfinavir mesylate" (1 trials), "Stavudine" (1 trials) and "Tenofovir disoproxil fumarate" (1 trials). Other intervention names were less common.

The vast majority of trials in "Dr Gerald Pierone Jr" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Dr Gerald Pierone Jr". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Dr Gerald Pierone Jr, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Dr Gerald Pierone Jr, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".